Company Origin

Specialità Fine Chemicals was established in 2013, through an initiative of Prati-Donaduzzi Group, aiming at the development of the manufacturing process of Active Pharmaceutical Ingredients (APIs) considered strategic for the company's business. We started the work focused on some generic anticancer drug substances.

For the development of the manufacturing processes of these products, a state-of-the-art organic synthesis laboratory with a total of 250 square-meters built-up area has been structured and equipped in order to allow the synthesis of organic compounds from the scale of units of grams up to the scale of hundreds of grams.

Specialità's R&D team is highly qualified, and is responsible for both development of manufacturing processes, as well as for development and validation of analytical methods of APIs and raw materials used in its manufacturing processes. In 2015, the company started the development of manufacturing process of Cannabidiol API through chemical synthesis, reaching the product of interest with high purity content.


To develop, produce and market high added value active pharmaceutical ingredients that meet Brazilian and international quality criteria and good manufacturing practices.


To be recognized for the high-level standard of the drug master files (DMFs) related to the active pharmaceutical ingredients it produces, and for the technical support offered to its customers in order to contribute to the shortening of deadlines and to the assertiveness of drug products submissions.


Ethics, respect and honesty
Search for excellence
Human Growth
Team spirit

Copyright © Specialità. All rights reserved. IT - Systems Development | Terms of use

A SPECIALITÀ respects your privacy and is concerned with the security of your information, always acting with transparency, for this reason, we have updated our ‘Terms of Use’ and ‘Privacy Policy’, we encourage you to review them.

O portal uses cookies to offer you the best possible experience during your access. By using our portal, you give your consent for us to use cookies. If you do not wish to receive our cookies, adjust your browser settings to learn more, click here.